India’s Biocon secures approval to use drug on Covid-19 patients
প্রকাশিত: ১২ জুলাই ২০২০, ০১:৩৫
India's Biocon Ltd has received regulatory approval for its drug Itolizumab to be used on coronavirus infected patients suffering from moderate to severe respiratory distress, the biopharmaceutical company said in a statement on Saturday. The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in